cellus is

Shift in the paradigm of cancer treatmentDevelopment of small molecules and biologics based on Tumor associated
macrophage (TAM) in vitro diagnostics / companion diagnostics.

Core Items

• First,

  Next-generation immuno-metabolic anti-cancer durg that responds to the immune evasion of cancer

  • - Development of anti-cancer drugs, antibody-durg conjugates
  • - Simultaneous development of antibody and small molecule compound pipeline

• Second,

  Development of companion diagnostic technology essential for successful anti-cancer drug development

  • - Development of a multi-immune antibody diagnostic chip based on liquid biopsy

Next-generated target for anti-cancer strategy : TAM (tumor-associated Macrophage)

Tumor-associated macrophages support cancer survival in the tumor microenvironment
Tumor-associated macrophages may be key players in the limitation of immunotherapies regulating CD8+ T cells